Morgridge Family Foundation gifts $3M to CSU Spur and College of Agricultural Sciences

The Morgridge Family Foundation has imparted a transformational gift of $3 million to support the Colorado State University College of Agricultural Sciences and educational program...

Learn More

Biodesix Announces Research Agreement with Top US Cancer Center

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it intends to develop a new novel minimal residual disease (MRD) te...

Learn More

Watchmaker Genomics Raises $40M Series A Financing to Accelerate Growth and Expand Clinical Sequencing Product Offerings

Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA, today announced it had secured...

Learn More

Brickell Biotech Doses First Subject in Phase 1 Study of DYRK1A Inhibitor BBI-02

Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription...

Learn More

AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus

AGC Biologics today announced it is adding viral vector suspension technology and capacity for the development and manufacturing of gene therapies at its commercial-grade campus in Longmont, Col., USA...

Learn More

Weekly Policy Update: Legislative Session Comes to a Close This Week

The legislative session is scheduled to end this Wednesday, May 11th. As we enter these final three days, the CBSA team continues to weigh in on key legislation and advocate on behalf of our life scie...

Learn More

New 450K-square-foot life science campus planned in Broomfield

Developer Scott Caldwell says life science companies needed this space "yesterday." Find out more in the Denver Business Journal article. A rendering of plans for Colorado Research ExchangeLINCOLN PRO...

Learn More

Umoja Biopharma Announces Activation of First ENLIGHTen Phase 1 Trial Site in Study of UB-TT170, a TumorTag that Targets Folate Receptors to Mark Tumors for Clearance by CAR T Cells

Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo for patients with solid and hematologic malignancies, announced...

Learn More

Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals

Brickell Biotech, Inc., a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmun...

Learn More

EvoEndo Poised to Transform Clinical Endoscopy Practice with the EvoEndo® Single-Use Unsedated Transnasal Endoscopy (TNE) System

EvoEndo®, Inc. (“EvoEndo”), a medical device company which developed a single use system that allows for unsedated Transnasal Endoscopy (TNE), has announced the completion of an $8.4 million Series A...

Learn More